The good news from Center for Devices and Radiological Health (CDRH)
This article was originally published in Clinica
In a most unusual move, Center for Devices & Radiological Health (CDRH) Director Bruce Burlington will write to company presidents and CEOs this week, describing the fine job the US agency is doing and its goals for the coming year. With a hostile Congress and dissatisfied industry association continually publicising CDRH problems, Dr Burlington may have felt the need to publicise some good news, reports Clinica's Washington correspondent, Duffy Miller.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.